InspireMD Inc/ US45779A8466 /
29/07/2024 21:59:55 | Chg. +0.01 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
3.37USD | +0.30% | 180 Turnover: 598.60 |
-Bid Size: - | -Ask Size: - | 3.37 | 3.29 |
GlobeNewswire
01/07
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
GlobeNewswire
28/05
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
14/05
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
07/05
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tu...
GlobeNewswire
26/03
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational...
GlobeNewswire
06/03
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GlobeNewswire
28/02
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Busine...
GlobeNewswire
12/02
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neu...
GlobeNewswire
31/01
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory...
GlobeNewswire
03/01
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...
GlobeNewswire
20/12/2023
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System
GlobeNewswire
27/11/2023
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...
GlobeNewswire
06/11/2023
InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
01/11/2023
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Devic...
GlobeNewswire
30/10/2023
InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Mo...
GlobeNewswire
12/10/2023
InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid St...
GlobeNewswire
03/10/2023
InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
GlobeNewswire
31/08/2023
InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exem...
GlobeNewswire
16/03/2022
InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Preventio...
GlobeNewswire
28/02/2022
InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial Following FDA Approva...